Mountain View, CA, February 19, 2003
IMPAC Medical Systems, Inc. (Nasdaq: IMPC), a leading
provider of information technology solutions for cancer care,
today announced a partnership with The Mattson Jack Group (MJG), a
consulting firm specializing in decision support for the
pharmaceutical and healthcare industries, to introduce
CancerMETRIC™. CancerMETRIC is a new, web-based oncology
informatics tool using MJG’s proprietary web interface. Powered by
IMPAC’s National Oncology Database (NODB™), SEER Data, and MJG’s
state-of-the-art modeling algorithms, CancerMETRIC improves
knowledge and understanding of cancer treatment and trends,
improves accuracy and consistency of cancer market information,
and accelerates market understanding.
“Since 1990, IMPAC has provided integrated management solutions
that combine core business functions such as scheduling and
billing with a specialized electronic medical record (EMR) for
oncology,” stated Joseph K. Jachinowski, president and CEO of
IMPAC. “In 1997, IMPAC expanded its suite of products to include a
full line of data aggregation and reporting tools that feed
IMPAC’s NODB. This joint project efficiently delivers the fruits
of those earlier efforts to the pharmaceutical and healthcare
providers.”
According to Richard Martin, president and COO of MJG, “Making
more informed and better decisions faster is increasingly
important in the expensive and hypercompetitive healthcare
industry of the 21st century. This is why we worked for almost two
years with IMPAC to develop CancerMETRIC, which is the first
database of its type designed to accelerate yet ease market
evaluation and understanding of important and complicated issues
surrounding cancer treatment and trends. IMPAC and MJG’s
collaboration has resulted in a database that provides a depth and
breadth of longitudinal, patient-based information that we feel is
an order of magnitude above any other information resource
currently available or under development.”
Jachinowski and Martin agree that IMPAC and MJG are both at the
forefront of oncology informatics. Jachinowski continued, “IMPAC
provides sophisticated, yet practical cancer registry and EMR
solutions capable of compiling valuable oncology data, and MJG
provides the analytical tools, skills, and oncology market
knowledge to turn raw data into valuable information for decision
support.”
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc. is a leading provider of information
technology systems for cancer care. IMPAC's products provide an
integrated clinical and administrative solution to manage the
complexities of cancer care, from detection and diagnosis through
treatment and follow-up. Specializing in the development of
practice management, electronic medical record, image management
and decision support software, IMPAC offers practical solutions
that help healthcare providers better manage the process of
delivering care. Additional information on IMPAC can be obtained
by visiting www.impac.com or calling 888-GO IMPAC.
About The Mattson Jack Group, Inc.
The Mattson Jack Group is a full-service consultancy formed in
1986, working exclusively in healthcare. Its ongoing mission is to
support client needs “…through advanced analysis, planning,
decision support, and implementation.” As with its other core
competencies, The Mattson Jack Group applies a comprehensive team
approach to custom oncology consulting – in science and technical
assessment, modeling and forecasting, commercial and therapeutic
area analysis, and in database development and management. For
more information about The Mattson Jack Group’s Practice
Specialties or CancerMETRIC™, please call 314-469-7600 or visit
the website at www.mattsonjack.com.
The statements contained in this press release that are not
purely historical are forward looking statements within the
meaning of Section 21E of the Securities and Exchange Act of 1934,
including statements regarding the Company's expectations,
beliefs, hopes, intentions or strategies regarding the future.
Forward looking statements include statements regarding the
Company's business strategy, timing of, and plans for, the
introduction of new products and enhancements, future sales,
market growth and direction, competition, market share, revenue
growth, operating margins and profitability. All forward looking
statements included in this document are based upon information
available to the Company as of the date hereof, and the Company
assumes no obligation to update any such forward looking
statement. Actual results could differ materially from the
Company's current expectations. Factors that could cause or
contribute to such differences include the Company's ability to
expand outside the radiation oncology market or expand into
international markets, integrate its products successfully with
related products and systems in the medical services industry,
reliance on distributors and manufacturers of oncology equipment
to market its products, and other factors and risks discussed in
the Company's Final Prospectus dated November 20, 2002 and other
reports filed by the Company from time to time with the Securities
and Exchange Commission. |
|
Michelle Arnold
Public Relations Manager
IMPAC Medical Systems, Inc.
650-623-8883
pr@impac.com
Link Disclaimer
|
